P

Inventor

RIES CAROLA

DE21 patents
⚠️ This page may combine multiple inventors who share the name “RIES CAROLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

18 patents
US9879085B2Jan 30, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE10 citations92
US9663580B2May 30, 2017

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE11 citations92
US9499625B2Nov 22, 2016

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE12 citations92
US9499624B2Nov 22, 2016

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE12 citations92
US9499626B2Nov 22, 2016

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE12 citations92
US9192667B2Nov 24, 2015

Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist

HOFFMANN LA ROCHE22 citations89
US10287358B2May 14, 2019

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE3 citations84
US10077314B1Sep 18, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE5 citations84
US10072087B2Sep 11, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE5 citations84
US10030073B2Jul 24, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE5 citations84
US10023643B2Jul 17, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE5 citations84
US9988458B2Jun 5, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE6 citations84
US9624302B2Apr 18, 2017

Nucleic acids encoding antibodies against human CSF-1R

HOFFMANN LA ROCHE11 citations84
US9617342B2Apr 11, 2017

Nucleic acids encoding antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE11 citations84
US10336830B2Jul 2, 2019

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE3 citations73
US11498968B2Nov 15, 2022

Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatment

HOFFMANN LA ROCHE2 citations62
US11512133B2Nov 29, 2022

Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1

HOFFMANN LA ROCHE0 citations60
US11542335B2Jan 3, 2023

Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)

HOFFMANN LA ROCHE0 citations52

FERTIG GEORG

2 patents

DIMOUDIS NIKOLAOS

1 patent